← All tickers

Is NUVB Worth Buying in 2026?

Nuvation Bio Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether Nuvation Bio Inc. (NUVB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.40% over 10 days); RSI 55 — healthy momentum range; strong 1-year return of +171.8%; 3-month momentum positive (+9.3%). Concerns: trading below the 200-day MA (long-term downtrend). Currently 49.5% off its 52-week high. Score: +3/7.

Ready to act on this? 📈 Trade on Webull

NUVB is trading below its 200-day MA ($5.27) — a key warning sign the longer-term trend is under pressure. An RSI of 54.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +171.8% compares to +22.9% for SPY (beat the market by 149.0%). The current 49.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $27,182 today
vs. S&P 500 (SPY) — same period beat market by 149.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($5.27)
✓Above 50-day MA ($4.73)
✓RSI(14) neutral zone (30–70) — currently 54.6
✓Positive return (+171.8%)
!Within 10% of period high (−49.5%)
Period Range $4.92
$1.57 $9.75
RSI (14) 54.6
0 · OversoldOverbought · 100

Key Metrics

Price$4.92
Period Return+171.8%
Period High$9.75
Period Low$1.57
Drawdown−49.5%
MA-50$4.73
MA-200$5.27
RSI (14)54.6
Avg Volume (30d)4.7M
vs. SPYbeat by 149.0%
Return Rank#113 of 1246

Trade NUVB

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers